2025 Annual Meeting | C1 - Cognitive, Behavioral, and Disease-modifying Therapeutics in Dementia

Date Saturday 04/05/25

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Location San Diego Convention Center | 25B

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Lealani M. Acosta, MD, MPH, FAAN

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should become familiar with the indication for and clinical utility of pharmacological and non-pharmacological therapeutics for dementia related cognitive and behavioral symptoms, and become familiar with the first ever disease modifying treatments for dementia and their role in clinical practice.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Systems-based Practice

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:35 AM PDT	Speaker	Non-pharmacological Management of Dementia Julio C. Rojas-Martinez, MD, PhD
07:35 AM - 08:10 AM PDT	Speaker	Pharmacological Management of Dementia Lealani M. Acosta, MD, MPH, FAAN
08:10 AM - 08:45 AM PDT	Speaker	Disease-modifying Therapies in Dementia Meredith Wicklund, MD, FAAN
08:45 AM - 09:00 AM PDT	Q&A	Questions and Answers Lealani M. Acosta, MD, MPH, FAAN, Meredith Wicklund, MD, FAAN, Julio C. Rojas-Martinez, MD, PhD

Faculty Disclosures
Lealani M. Acosta, MD, MPH, FAAN	Dr. Acosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Acosta has received research support from AbbVie, Sage, NIH, Bristol Myers Squibb/Fortrea, CND Life Sciences.
Meredith Wicklund, MD, FAAN	The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Julio C. Rojas-Martinez, MD, PhD	Dr. Rojas-Martinez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferrer International, S.A.. The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. The institution of Dr. Rojas-Martinez has received research support from Amylyx.